Browsing by Author Hudson, Amanda

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
2014Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesotheliomaClarke, Stephen; Harvie, Rozelle; Howell, Viive; Hudson, Amanda; Moon, Elizabeth; Pavlakis, Nick; Weir, Christopher; Klebe, Sonja; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: MedicineEstablishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma, Scientific Reports, vol.4, N/A, 2014,pp 1-11
2015EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma.Espinoza, David; Hudson, Amanda; Long, Anne; Martin, Andrew; Pavlakis, Nick; Stockler, Martin; Thompson, John; Yip, Sonia; Azad, A; Davis, I D; Goldstein, David; Harrision, M; Harvie, R; Jovanovic, L; Kannourakis, G; Kichenadasse, G; Lowenthal, Raymond M.; Nelson, C C; Shapiro, J; Steer, C; NH&MRC Clinical Trials Centre; Northern Clinical School: Kolling Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Surgery; NH&MRC Clinical Trials CentreEVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first line therapy for advanced renal cell carcinoma., Annals of Oncology, vol.26, 6, 2015,pp 1118-1123
2014From mice to men: GEMMs as trial patients for new NSCLC therapiesClarke, Stephen; Hayes, Sarah; Howell, Viive; Hudson, Amanda; Molloy, Mark; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteFrom mice to men: GEMMs as trial patients for new NSCLC therapies, Seminars in Cell & Developmental Biology, vol.27, N/A, 2014,pp 118-127
2016Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastomaChen, Jason; Cheng, Zhangkai; Dwight, Trisha; Howell, Viive; Hudson, Amanda; Ikin, Rowan; Khong, Peter; Parker, Nicole Renee; Parkinson, Jonathon; Vafaee, Fatemeh; Wheeler, Helen; Zhu, Ying; Northern Clinical School: Pathology; Physics; Northern Clinical School: NCS Office; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Mathematics & Statistics; Northern Clinical School: Medicine; Northern Clinical School: MedicineIntratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma, Scientific Reports, vol.6, N/A, 2016,pp 1-10
2015Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma ModelHowell, Viive; Hudson, Amanda; Peters, Lyndsay; Weir, Christopher; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineOrthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model, Journal of Visualized Experiments, vol.104, N/A, 2015,pp 1-12
2015Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion InjuryAshton, Anthony; Hudson, Amanda; Le, Thi Yen Loan; Mihailidou, Anastasia Susie; Morel-Kopp, Marie-Christine; Gomez-Sanchez, Celso E; McWhitney, Brett; Northern Clinical School: Obstetrics & Gynaecology; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: MedicineRole of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury, Molecular Endocrinology, vol.29, 8, 2015,pp 1144-1155
2014Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccinesDavey, Ross; Howell, Viive; Hudson, Amanda; Pavlakis, Nick; Peters, Lyndsay; Weir, Christopher; Alexander, Miles; Clarke, Stephen; Langova, Veronika; Moon, Elizabeth; Ross, Angus; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineStreptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines, Cancer Immunology Research, vol.2, 5, 2014,pp 469-479
2014Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccinesDavey, Ross; Howell, Viive; Hudson, Amanda; Pavlakis, Nick; Peters, Lyndsay; Weir, Christopher; Alexander, Miles; Clarke, Stephen; Langova, Veronika; Moon, Elizabeth; Ross, Angus; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineStreptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines, Cancer Immunology Research, vol.2, 5, 2014,pp 469-479
2014Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccinesDavey, Ross; Howell, Viive; Hudson, Amanda; Pavlakis, Nick; Peters, Lyndsay; Weir, Christopher; Alexander, Miles; Clarke, Stephen; Langova, Veronika; Moon, Elizabeth; Ross, Angus; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineStreptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines, Cancer Immunology Research, vol.2, 5, 2014,pp 469-479
2014Streptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccinesDavey, Ross; Howell, Viive; Hudson, Amanda; Pavlakis, Nick; Peters, Lyndsay; Weir, Christopher; Alexander, Miles; Clarke, Stephen; Langova, Veronika; Moon, Elizabeth; Ross, Angus; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineStreptavidin: a novel immunostimulant for the selection and delivery of autologous and syngeneic tumor vaccines, Cancer Immunology Research, vol.2, 5, 2014,pp 469-479
2014SV40 TAg mouse models of cancerColvin, Emily; Hudson, Amanda; Ikin, Rowan; Weir, Christopher; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineSV40 TAg mouse models of cancer, Seminars in Cell & Developmental Biology, vol.27, N/A, 2014,pp 61-73
2016Transgenic mouse models of SV40-induced cancerColvin, Emily; Hudson, Amanda; Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling InstituteTransgenic mouse models of SV40-induced cancer, ILAR Journal, vol.57, 1, 2016,pp 44-54